China Feihe (06186) spent 8.8511 million Hong Kong dollars on November 12 to repurchase 2 million shares.

17:18 12/11/2025

China Feihe (06186) announced that on November 12, 2025, the company invested 885.11 million...

CHINA FEIHE (06186) announced that on November 12, 2025, the company will spend 8.8511 million Hong Kong dollars to repurchase 2 million shares, with a repurchase price of 4.42-4.43 Hong Kong dollars per share.

APPOINTED CHENG Zhi Cong as Secretary of Vital Inno (06133)

Shareholder Zhang Hongjing's 1st selection of Jiangsu Apon Medical Technology (300753.SZ) plans to reduce its holdings by no more than 2%.

BEONE MEDICINES (06160) releases its performance for the first three quarters, with a net profit attributable to the parent company of 1.139 billion yuan, turning a loss into a profit year-on-year.

APPOINTED CHENG Zhi Cong as Secretary of Vital Inno (06133)

Shareholder Zhang Hongjing's 1st selection of Jiangsu Apon Medical Technology (300753.SZ) plans to reduce its holdings by no more than 2%.

BEONE MEDICINES (06160) releases its performance for the first three quarters, with a net profit attributable to the parent company of 1.139 billion yuan, turning a loss into a profit year-on-year.